Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

BIO Attendees – Get a free preview of our book when it launches on July 1st Name Email HP Make Better Decisions helps generic and branded companies alike find and evaluate…
The post Make Better Decisions: Finding and Evaluating Generic and Branded Drug…


Patent delisted for Teva Branded drug PROAIR RESPICLICK

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post Patent delisted for Teva Branded drug PROAIR RESPICLICK …


Patent delisted for Teva Branded drug PROAIR DIGIHALER

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post Patent delisted for Teva Branded drug PROAIR DIGIHALER app…


Patent delisted for Eli Lilly drug EFFIENT

Annual Drug Patent Expirations for EFFIENT Effient is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post Patent delisted for Eli Lilly drug EFFIENT appeared first on DrugPatentWatch – …


Patent delisted for Purdue Pharma drug OXYCONTIN

Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from twelve suppliers. There are twenty…
The post Patent delisted for Purdue Pharma drug OXYCONTIN appeared first …


Patent delisted for Astellas drug LEXISCAN

Annual Drug Patent Expirations for LEXISCAN Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are seventeen patents protecting…
The post Patent delisted for Astellas drug LEXISCAN appeared firs…


New patent for Astrazeneca drug CALQUENCE

Annual Drug Patent Expirations for CALQUENCE Calquence is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent for Astrazeneca drug CALQUENCE appeared first…


New patent for Pharmacyclics Inc drug IMBRUVICA

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are twenty-nine patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appea…


New patent for Allergan Sales drug GELNIQUE

Annual Drug Patent Expirations for GELNIQUE Gelnique is a drug marketed by Allergan Sales Llc and is included in two NDAs. It is available from two suppliers. There are six…
The post New patent for Allergan Sales drug GELNIQUE appeared first on DrugPat…


Do NOT follow this link or you will be banned from the site!